| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/03/2008 | CA2672980A1 Shrna-mediated inhibition of expression of alpha-1.6-fucosyltransferase |
| 07/03/2008 | CA2672979A1 Selection method |
| 07/03/2008 | CA2672944A1 Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disorders |
| 07/03/2008 | CA2672916A1 Cd44 antibodies |
| 07/03/2008 | CA2672750A1 Trkb agonists for treating autoimmune disorders |
| 07/03/2008 | CA2672715A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 07/03/2008 | CA2671903A1 Dr6 antagonists and uses thereof in treating neurological disorders |
| 07/03/2008 | CA2671900A1 Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| 07/03/2008 | CA2671585A1 Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof |
| 07/03/2008 | CA2669571A1 Pesticide biomarker |
| 07/02/2008 | EP1939779A2 Systems and methods for biopolymer engineering |
| 07/02/2008 | EP1939297A1 Alzheimer's disease secretase |
| 07/02/2008 | EP1939295A1 Vaccine compostions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/02/2008 | EP1939293A2 Interferon-Like Protein ZCYTO21 |
| 07/02/2008 | EP1939288A1 T-cell adhesion molecule and antibody directed against the molecule |
| 07/02/2008 | EP1939286A1 Novel peptides |
| 07/02/2008 | EP1938834A1 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 07/02/2008 | EP1938106A1 Detection or quantification of aggrecan and its fragments |
| 07/02/2008 | EP1938100A2 Identification of novel protein targets on the surface of stressed cells |
| 07/02/2008 | EP1937851A2 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 07/02/2008 | EP1937827A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 07/02/2008 | EP1937815A1 Methods and compositions for modulating tumor cell activity |
| 07/02/2008 | EP1937814A2 Anti-apoptotic protein antibodies |
| 07/02/2008 | EP1937723A1 Modified chaperonin 10 |
| 07/02/2008 | EP1937722A2 Antibodies directed against an ldl receptor |
| 07/02/2008 | EP1937721A2 Anit-il-23 antibiodies |
| 07/02/2008 | EP1937720A2 Single chain antibodies against beta-amyloid peptide |
| 07/02/2008 | EP1937709A1 A marker for prolonged rupture of membranes |
| 07/02/2008 | EP1937314A2 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| 07/02/2008 | EP1937313A2 Host cell lines for production of antibody constant region with enhanced effector function |
| 07/02/2008 | EP1937307A2 Specific removal of activated immune cells |
| 07/02/2008 | EP1937306A2 Proteolysis resistant antibody preparations |
| 07/02/2008 | EP1694845A4 Anticarcinoma antibidies and uses thereof |
| 07/02/2008 | EP1572747B1 Tumor-specific recognition molecules |
| 07/02/2008 | EP1539199A4 Methods and compositions for in vivo clearance of pathogens |
| 07/02/2008 | EP1366455B1 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 07/02/2008 | EP1171468B1 Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2-scFv Fragment |
| 07/02/2008 | EP1169347B1 Compounds and methods for therapy and diagnosis of lung cancer |
| 07/02/2008 | EP1012248B1 Novel thermophilic polymerase iii holoenzyme |
| 07/02/2008 | EP0966300B1 Treatment of rheumatoid arthritis with antibody anti ifn gamma |
| 07/02/2008 | EP0896055B1 Apoptosis inducing protein and gene encoding the same |
| 07/02/2008 | CN101213297A Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics |
| 07/02/2008 | CN101213214A Single domain VHH antibodies against von willebrand factor |
| 07/02/2008 | CN101213213A Cardiovascular disease therapies |
| 07/02/2008 | CN101213212A Methods and compositions for impairing multiplication of HIV-1 |
| 07/02/2008 | CN101213211A Methods of purifying Fc region containing proteins |
| 07/02/2008 | CN101213210A Polypeptide, vaccine and use thereof |
| 07/02/2008 | CN101213205A Group B streptococcus |
| 07/02/2008 | CN101210919A HIV-EnvHIV-Env gene DNA recombinant envelope protein antigen immune response experiment and method for resisting HIV |
| 07/02/2008 | CN101210244A Neutrokine-alpha and Neutrokine-alpha splice variants |
| 07/02/2008 | CN101210051A Anti-VEGF antibodies |
| 07/02/2008 | CN101210050A Anti-vegf antibodies |
| 07/02/2008 | CN101210049A Immunosuppressant-anti-CD25 mosaic monoclonal antibody |
| 07/02/2008 | CN101210048A Anti-CD33 engineering antibody for target conjugated marrow series leukemia cell and its expression vector and use |
| 07/02/2008 | CN100398563C Anti-human marrow mesenchyma stem cell monoclonal antibody ZUC3 and its uses |
| 07/02/2008 | CN100398562C Monoclonal antibody ZUF10 of human bone marrow mesenchymal stem cells and application |
| 07/02/2008 | CN100398561C Anti-human marrow mesenchymal stem cell monoclonal antibudy ZUB4 and use |
| 07/02/2008 | CN100398560C Anti-human marrow mesenchymal stem cell monoclonal antibody ZUE12 and use |
| 07/02/2008 | CN100398559C Anti-HBeAg monoclonal antibody and its cell strain, prepn. method and use thereof |
| 07/02/2008 | CN100398551C Novel isoforms of vascular endothelial cell growth inhibitor |
| 07/02/2008 | CN100398152C Novel human beta 2 integrin alpha subunit |
| 07/01/2008 | US7393939 Transport protein for use in the removal of the xenobiotics from mammals |
| 07/01/2008 | US7393934 Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 07/01/2008 | US7393933 Hepatitis B monoclonal antibodies |
| 07/01/2008 | US7393932 Endothelial cell expression patterns |
| 07/01/2008 | US7393931 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/01/2008 | US7393920 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving |
| 07/01/2008 | US7393831 prophylactic and therapeutic vaccination directed against the hepatitis C virus |
| 07/01/2008 | US7393684 Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies |
| 07/01/2008 | US7393683 Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase |
| 07/01/2008 | US7393682 Polynucleotides encoding promyostatin polypeptides |
| 07/01/2008 | US7393673 Mixture containing glucanase for use in degradation of plant biomass and pollution control |
| 07/01/2008 | US7393666 Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis |
| 07/01/2008 | US7393662 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393651 Confluence regulated adhesion molecules useful in modulating vascular permeability |
| 07/01/2008 | US7393650 Using hybridoma cells to generate monoclonal antibody specific to 7-transmembrane receptor protein for use in the diagnosis, prevention and treatment of psychological and nervous system disorders |
| 07/01/2008 | US7393649 Using protrein oxidation as diagnostic tool in detection of arthritic, cell proliferative, nervous system and autoimmue disorders |
| 07/01/2008 | US7393648 Hybrid antibodies |
| 07/01/2008 | US7393540 Therapeutic peptide for prevention of microorganismal infections; enzyme inhibitors; RNA inteference; antisense agents |
| 07/01/2008 | US7393539 Therapeutic agent for prevention and treatment of bacterial infection; bactericides; genetic vaccines; immunotherapy |
| 07/01/2008 | US7393531 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 07/01/2008 | US7393530 IL-1-like cytokine antibodies |
| 07/01/2008 | US7393529 Antiallergens |
| 06/26/2008 | WO2008076379A2 Human antibodies to human delta like ligand 4 |
| 06/26/2008 | WO2008076321A1 Engineered anti-tslp antibody |
| 06/26/2008 | WO2008076127A1 Inhibitory polynucleotide compositions and methods for treating cancer |
| 06/26/2008 | WO2008075962A1 An activation epitope of fcy rii (cd32), binding molecules that specifically bind the epitope and means and methods for the detection of the epitope, and uses of said epitope or said binding molecules. |
| 06/26/2008 | WO2008075788A1 Avian-derived antibody capable of binding specifically to human hmgb1, immunological determination method for human hmgb1, and immunological determination reagent for human hmgb1 |
| 06/26/2008 | WO2008075374A1 A recombinant mouse-human chimeric fab against hepatitis b surface antigen |
| 06/26/2008 | WO2008075363A1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 06/26/2008 | WO2008075349A1 Therapeutic methods using a thymus peptide |
| 06/26/2008 | WO2008075174A2 Lysosomal associated membrane protein (lamp) - like polypeptide, ligands to the same, and use of the same in the frame of detection and purification of human plasmacytoid dendritic cells |
| 06/26/2008 | WO2008075045A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | WO2008075038A1 Binding agents to the integrin alpha-11 subunit |
| 06/26/2008 | WO2008074867A2 Anti-fc-receptor single domain antibodies (nanobodies-tm) and therapeutic use |
| 06/26/2008 | WO2008074840A2 Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders |
| 06/26/2008 | WO2008074839A2 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
| 06/26/2008 | WO2008074424A2 Coding genes with a single exon for new bioactive peptides |
| 06/26/2008 | WO2008074079A1 Identification of candidate vaccine antigens from dichelobacter nodosus |